Accelerate to discover

Back to filter

Related topics

ACCELA Educational webinar series: Unlocking Spatial Biology with RareCyte Orion Technology

RareCyte

Nov 16, 2022

Discover full slide, high-plex biomarker quantitation with the all-in-one spatial biology...

Practical aspects of an imaging study: live in vivo scanning

MOLECUBES

Nov 11, 2022

In this webinar, MOLECUBES will present a live in vivo demonstration, showing the entire workflow from animal...

All inside your incubator: xCELLigence eSight

Agilent technologies

Nov 3, 2022

Multiplex Live cell imaging and real-time biosensor measurement with xCELLigence eSight

Download the newest AVATAR data presented at CAR-TCR

Xcell Biosciences

Oct 21, 2022

Xcell Bio CSO, James Lim, presented new data showcasing improved potency of AVATAR-expanded CAR T cells and highlighted...

Nov 27, 2022

RareCyte Orion system advances Multi-modal digital pathology for colorectal cancer diagnosis

RareCyte

Oct 19, 2022

Precision medicine is critically dependent on better methods for diagnosing and staging disease and predicting drug...

Introducing MARS system : revolutionary solution for your workflow of cell separation and enrichment

Applied Cells

Oct 7, 2022

The MARS family of instruments provides a breakthrough solution to complete the workflow of cell separation and...

AMI HTX installation in CEMEX Iasi, Romania

Spectral Instruments Imaging

Sep 30, 2022

Presentation movie

Nov 27, 2022

Introducing RareCyte Orion, integrating Spatial Biology with Multiplex Imaging

RareCyte

Sep 13, 2022

Orion, the highly multiplexed fluorescent imaging system, empower investigators to unlock spatial context for key...

Show all topics (10)

Multi-modal PET drives interdisciplinary preclinical imaging

Feb 23, 2022

Preclinical imaging (PCI) plays a vital role in understanding the biological processes behind disease states at the organ, tissue, cell and molecular level. Elucidating how the body responds to physiological or environmental change is important in the search for therapeutic agents to fight disease. PCI is also critical to the evaluation of new treatment effectiveness and safety, by informing researchers of drug distribution patterns in tissues. PET in preclinical studies enables users to conduct repeat experiments on the same animal subjects, providing strong statistically valuable data and therefore reducing the number of animals required for a study. For this reason, it has becoming increasingly important to use non-invasive in vivo imaging techniques to optimize the use of each animal used.

Multi-modal tomographs, such as PET/CT, allow the correlation of the functional imaging obtained using PET with the anatomic imaging obtained with CT scanning. PET can also be combined with other technologies, such as magnetic resonance imaging (MRI), to bring functional imaging together with soft tissue morphological imaging. PET/MR is gaining ground in preclinical imaging applications, as it offers superior soft tissue contrast, imaging without the CT’s ionizing radiation risk, and multiparametric data.

Do you want to learn more? Just ask us!

 

Scientific paper
Application

Related technologies: Magnetic resonance imaging

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 210 323 421

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

MRI and PET imaging combined for the best of both worlds

show detail

Multi-purpose high field MRI/MRS research systems, designed for the preclinical imaging and molecular MRI

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey